Funding for this research was provided by:
national key research and development program of china (2018YFC2001905)
Received: 3 July 2021
Accepted: 15 July 2022
First Online: 16 August 2022
: The study protocol (2020PHB107) was approved by the Ethics Committee of Peking University People’s Hospital, Beijing, China (Chairperson Prof. S. Mu), which waived the requirement for informed consent because of the retrospective design.Clinical trial registry: ChiCTR1800014508 (ExternalRef removed, Jan 17, 2018; Hong Zhao, M.D.). URL: ExternalRef removed
: Not applicable.
: The authors declare that they have no competing interests.